# Uribel Tabs (METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFAT) by Cintex Services, LLC: new human prescription drug listing

**Launch Signal Score:** 40/100

| Field | Value |
|---|---|
| Product | Uribel Tabs |
| Generic name | METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFATE |
| NDC | 24470-967 |
| Labeler | Cintex Services, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | UNAPPROVED DRUG OTHER |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | METHENAMINE 81.6 mg/1; BENZOIC ACID 9 mg/1; PHENYL SALICYLATE 36.2 mg/1; METHYLENE BLUE 10.8 mg/1; HYOSCYAMINE SULFATE .12 mg/1 |
| Marketing start | 2026-10-05 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=24470-967). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.